Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04141917 · ClinicalTrials.gov registry record · Phase 4
Test-and-treat for Influenza in Homeless Shelters
A Phase 4 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1,618
- Enrollment target
NCT04141917: Clinical Trial Phase 4 study, sponsored by University of Washington.
NCT04141917 is a Phase 4 study that was terminated before completion, run by University of Washington. The registered enrollment target is 1,618 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (212% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04141917, a Phase 4 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1,618 participants
- Enrollment target
Study Summary
This study is a stepped-wedge cluster-randomized trial of on-site rapid testing and treatment for influenza in homeless shelters within the Seattle area to determine whether this strategy reduced the incidence of influenza in the shelter environment.
Primary Outcome
The intervention period is when test and treatment on-site was available and the control period is when just standard surveillance was available at a shelter.
Interventions
- COMBINATION_PRODUCT Point-of-care molecular testing and treatment of influenza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,618 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2021-03-31 |
| Phase | Phase 4 |
Why NCT04141917 stopped before completion
NCT04141917 is an interventional study that assigns participants to a tested intervention. Its 1,618 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (212% higher).
The record links to 0 conditions, and to 1 intervention - of which Point-of-care molecular testing and treatment of influenza is the first listed.
NCT04141917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04141917 about?
NCT04141917 is a clinical study titled "Test-and-treat for Influenza in Homeless Shelters". This study is a stepped-wedge cluster-randomized trial of on-site rapid testing and treatment for influenza in homeless shelters within the Seattle area to determine whether this strategy reduced the incidence of influenza in the shelter environment.
What is the current status of trial NCT04141917?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1,618 participants. The study started on 2019-11-15. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT04141917?
The interventions under investigation include: Point-of-care molecular testing and treatment of influenza (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04141917?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04141917's enrollment target sits among peer trials
1,618 48th of 2000 higher than 1,953 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI